BNTX
Depositary ReceiptBioNTech SE
Reported Shares
682.1K
Position Mix
No options reported
Reported Value
$67.1M
Portfolio Weight
13.04%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$514.1M
Data Refreshed
Nov 16, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
BNTX
Depositary ReceiptBioNTech SE
Reported Shares
682.1K
Position Mix
No options reported
Reported Value
$67.1M
Portfolio Weight
13.04%
RPRX
Common StockRoyalty Pharma plc
Reported Shares
974.4K
Position Mix
No options reported
Reported Value
$56.9M
Portfolio Weight
11.06%
INSM
Common StockINSMED Inc
Reported Shares
496K
Position Mix
No options reported
Reported Value
$56.6M
Portfolio Weight
11.01%
ROIV
Common StockRoivant Sciences Ltd.
Reported Shares
1.5M
Position Mix
No options reported
Reported Value
$53.9M
Portfolio Weight
10.48%
IONS
Common StockIONIS PHARMACEUTICALS INC
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$48.5M
Portfolio Weight
9.44%
ARGX
Depositary ReceiptARGENX SE
Reported Shares
37.6K
Position Mix
No options reported
Reported Value
$36.1M
Portfolio Weight
7.01%
REGN
Common StockREGENERON PHARMACEUTICALS, INC.
Reported Shares
40.7K
Position Mix
No options reported
Reported Value
$30.8M
Portfolio Weight
6.00%
NTRA
Common StockNatera, Inc.
Reported Shares
63.2K
Position Mix
No options reported
Reported Value
$26.1M
Portfolio Weight
5.08%
ABVX
Depositary ReceiptAbivax S.A.
Reported Shares
219.2K
Position Mix
No options reported
Reported Value
$21.7M
Portfolio Weight
4.22%
VERA
Common StockVera Therapeutics, Inc.
Reported Shares
628.3K
Position Mix
No options reported
Reported Value
$20.3M
Portfolio Weight
3.95%
MLYS
Common StockMineralys Therapeutics, Inc.
Reported Shares
695.2K
Position Mix
No options reported
Reported Value
$17.5M
Portfolio Weight
3.40%
LEGN
Depositary ReceiptLegend Biotech Corp
Reported Shares
828.9K
Position Mix
No options reported
Reported Value
$16.5M
Portfolio Weight
3.21%
ARWR
Common StockARROWHEAD PHARMACEUTICALS, INC.
Reported Shares
229.3K
Position Mix
No options reported
Reported Value
$15.0M
Portfolio Weight
2.92%
LLY
Common StockELI LILLY & Co
Reported Shares
12.6K
Position Mix
No options reported
Reported Value
$14.6M
Portfolio Weight
2.84%
GENB
Common StockGenerate Biomedicines, Inc.
Reported Shares
824.7K
Position Mix
No options reported
Reported Value
$12.4M
Portfolio Weight
2.41%
VRDN
Common StockViridian Therapeutics, Inc.\DE
Reported Shares
560.7K
Position Mix
No options reported
Reported Value
$11.5M
Portfolio Weight
2.25%
AVTX
Common StockAvalo Therapeutics, Inc.
Reported Shares
564.4K
Position Mix
No options reported
Reported Value
$8.7M
Portfolio Weight
1.68%